Molecular Partners AG (MLLCF) Financials

MLLCF Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 109.7 million 24.0 million
Dec. 31, 2025 128.8 million 27.5 million
Sept. 30, 2025 140.8 million 20.9 million
June 30, 2025 156.7 million 22.2 million

MLLCF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -17.7 million ?
Dec. 31, 2025 -13.8 million 1.2 million
Sept. 30, 2025 -12.5 million 1.4 million
June 30, 2025 -16.6 million 1.5 million

MLLCF Net Income

No data available :(

MLLCF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 98.6 million - 2.7 million
Dec. 31, 2025 117.3 million - 3.1 million
Sept. 30, 2025 131.2 million - 1.9 million
June 30, 2025 144.4 million - 2.3 million

MLLCF Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 46.8 million
Dec. 31, 2025 47.2 million
Sept. 30, 2025 47.0 million
June 30, 2025 47.2 million

MLLCF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 11.8 million 4.4 million -
Dec. 31, 2025 175276 11.7 million 3.7 million -
Sept. 30, 2025 38924 10.5 million 4.5 million -
June 30, 2025 121080 13.5 million 5.0 million -

MLLCF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 627009
Dec. 31, 2025 - 646884
Sept. 30, 2025 - 10.5 million
June 30, 2025 - -

MLLCF

Price: $4.85

52 week price:
2.25
4.85

Earnings Per Share: -1.97 USD

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 181.9 million

Links: